MT‐RNR1 genotype testing for preventing aminoglycoside‐mediated ototoxicity: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI‐PGx)

British Journal of Clinical Pharmacology · Published 2026-07-29 · DOI 10.1002/bcp.70712

Free full text

Authors (17)

John H. McDermott, Sian Hilton, Cinzia Dello Russo, Nicola Booth, Simon Drysdale, Philip Howard, Stephen Hughes, Mallinath Chakraborty, Helen McDevitt, Charlotte Alston, Maya Desai, Mike Beadsworth, Adam Reynolds, Serim Min, Katherine Payne, Munir Pirmohamed, William G. Newman

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

McDermott, J., Hilton, S., Russo, C., et al. (2026). MT‐RNR1 genotype testing for preventing aminoglycoside‐mediated ototoxicity: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI‐PGx). British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70712

Related articles

• Single-Dose Gentamicin vs Standard Care for Treatment of Acute Uncomplicated Cystitis in Premenopausal Women: A Randomized Trial · Journal of Pharmacy Practice · 2025 · Cites or is cited by this article
• Relationships among nitrous oxide exposure, neurological injury and biomarkers · British Journal of Clinical Pharmacology · 2026 · Same journal
• Predicting cognitive function in Alzheimer's clinical trials via amyloid β‐protein biomarkers · British Journal of Clinical Pharmacology · 2026 · Same journal
• Comparative risk of ventricular arrhythmia and sudden cardiac death among acetylcholinesterase inhibitors in dementia: A population‐based cohort study · British Journal of Clinical Pharmacology · 2026 · Same journal
• Pharmacogenomics of dolutegravir: A scoping review of evidence, gaps and clinical implications · British Journal of Clinical Pharmacology · 2026 · Same journal
• Population pharmacokinetics and pharmacodynamics of canagliflozin in paediatric patients with type 2 diabetes mellitus · British Journal of Clinical Pharmacology · 2026 · Same journal
• Trends in publicly subsidized and private access to GLP‐1 medicines indicated for type 2 diabetes in Australia, 2020–2025 · British Journal of Clinical Pharmacology · 2026 · Same journal
• Analysis of spontaneous reports of suspected adverse reactions related to medical cannabis from the Italian Phytovigilance System · British Journal of Clinical Pharmacology · 2026 · Same journal
• A university‐certified course on dossier assessment for regulatory scientists in Africa—Reporting on our 5‐year experience · British Journal of Clinical Pharmacology · 2026 · Same journal
• Perceptions of prescribing violations by doctors: A qualitative study using semi‐structured interviews · British Journal of Clinical Pharmacology · 2026 · Same journal